HUMANIGEN, INC.
HGEN
HGEN was delisted on the 25th of July, 2023.
48 hedge funds and large institutions have $858K invested in HUMANIGEN, INC. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 10 closing their positions.
108% more call options, than puts
Call options by funds: $25K | Put options by funds: $12K
9% less funds holding
Funds holding: 53 → 48 (-5)
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
36% less capital invested
Capital invested by funds: $1.34M → $858K (-$479K)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$90.3K |
| 2 |
Bank of New York Mellon
New York
|
+$38.1K |
| 3 |
VF
Virtu Financial
New York
|
+$30.2K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$27.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$185K |
| 2 |
Millennium Management
New York
|
-$47.1K |
| 3 |
Man Group
London,
United Kingdom
|
-$16K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$11K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.85K |
HGEN Hedge Fund Activity: Q4 2022 in Review
48 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q4 2022, worth a combined $858K — down 36% from $1.34M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HGEN and 6 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 13 added.
The largest buyer was Renaissance Technologies, adding an estimated $90.3K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $185K sold.
- 48 institutional investors held HUMANIGEN, INC. (HGEN) as of Q4 2022, down from 53 in Q3 2022.
- Funds reported $858K of HUMANIGEN, INC. stock for Q4 2022, down 36% quarter-over-quarter.
- 6 funds opened new HUMANIGEN, INC. positions in Q4 2022 and 10 closed out, a net change of -4 holders.
- The largest HUMANIGEN, INC. buyer in Q4 2022 was Renaissance Technologies, an estimated $90.3K added.
- The largest HUMANIGEN, INC. seller in Q4 2022 was GSA Capital Partners, an estimated $185K sold.
Based on aggregated 13F filings for Q4 2022.